Rosuvastatin has possible interactions with alcohol, some other drugs, and certain supplements. Examples include antacids that include magnesium. Talk with your doctor to avoid potentially harmful ...

Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...

Research specifically addressing the efficacy of rosuvastatin versus atorvastatin in patients with ischemic stroke is insufficient. Using a large stroke registry, we investigated whether 2 commonly ...

Crestor (rosuvastatin) and Lipitor (atorvastatin) are the top medications for lowering blood levels of cholesterol and triglycerides. High cholesterol (and triglycerides) occurs when the fat in your ...

The other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the ...

A recent study from Johns Hopkins University suggests that a popular cholesterol-lowering drug, rosuvastatin, may increase the risk of kidney problems, especially at higher doses. This finding could ...

For lowering your cholesterol levels, taking medication is a possible option. But there's one kind that has the potential to raise your blood sugar levels.

However, the combination of drugs also increases the risk of adverse events (AEs). In this study, we analyzed the safety signals of rosuvastatin-fenofibrate combination by assessing the publicly ...

Purpose: The combination therapy of rosuvastatin (RSV) and the platelet inhibitor clopidogrel (CP) is widely accepted in the management of cardiovascular diseases. The objective of the present study ...

ATP = Adult Treatment Panel; BAR = bile acid resin; BMI = body mass index; CHD = coronary heart disease; CVA = cerebral vascular accident; HDL-C = high-density lipoprotein cholesterol. a n = 44.

He then explores the comparative effectiveness and safety of atorvastatin versus rosuvastatin. Finally, Dr. Eagle discusses the results of the RESET-BP randomized trial that studied the effects of ...

在快速变化的医药行业中，尖峰集团引领着创新前行的步伐。近日，尖峰集团宣布其全资子公司尖峰药业的化学原料药——罗沙司他（Rosuvastatin），已成功获得国家药品监督管理局的上市批准通知书。这一消息可谓是业界的一剂强心针，不仅增强了尖峰药业的市场竞争力，更为公司的业务拓展打开了新的大门。